B cell-depleting anti-CD19 monoclonal antibody holds promise for treating IgG4-related cholangitis. Trampert DC. J Hepatol 2025 Feb 27:S0168-8278(25)00070-4. doi: 10.1016/j.jhep.2025.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Trampert DC. B cell-depleting anti-CD19 monoclonal antibody holds promise for treating IgG4-related cholangitis. J Hepatol 2025 Feb 27:S0168-8278(25)00070-4. doi: 10.1016/j.jhep.2025.
PMID: 40021374